Who owns REVIVA PHARMACEUTCLS HLDGS I?
- Ticker: RVPH
- CUSIP Number: 76152g100
Tip: Access positions for across all investors
Analyze quarterly positions in Reviva Pharmaceutcls Hldgs I with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Reviva Pharmaceutcls Hldgs I stock
Who bought or sold REVIVA PHARMACEUTCLS HLDGS I this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Vanguard Group | 975k | $5.0M | 58% | Dec 2023 |
|
Millennium Management | 856k | $4.4M | 49% | Dec 2023 |
|
Citadel Advisors | 339k | $1.7M | -12% | Dec 2023 |
|
Polar Securities | 155k | $797k | 100% | Dec 2023 |
|
EMC Capital Management | 124k | $638k | 0% | Dec 2023 |
|
Colony | 121k | $623k | 100% | Dec 2023 |
|
Caption Management | 116k | $595k | -76% | Dec 2023 |
|
Man Group | 49k | $253k | 100% | Dec 2023 |
|
Two Sigma Investments | 42k | $214k | 172% | Dec 2023 |
|
Marshall Wace | 39k | $201k | 100% | Dec 2023 |
|
Jane Street | 29k | $150k | 100% | Dec 2023 |
|
Virtu Financial | 15k | $78k | 100% | Dec 2023 |
|
Bank of America Corporation | 15k | $77k | 1498500% | Dec 2023 |
|
Vontobel Holding | 14k | $72k | 100% | Dec 2023 |
|
Torno Capital | 13k | $65k | 100% | Dec 2023 |
|
Wolverine Asset Management | 4.6k | $24k | -67% | Dec 2023 |
|
Cutler | 3.0k | $11k | 0% | Mar 2024 |
|
ADAR1 Capital Management | 2.5k | $13k | 100% | Dec 2023 |
|
Jpmorgan Chase & Co | 917.00 | $4.7k | 100% | Dec 2023 |
|
Archer Investment Corp | 500.00 | $2.6k | 0% | Dec 2023 |
|
Wells Fargo & Company | 139.00 | $716.002900 | -97% | Dec 2023 |
|
Royal Bank of Canada | 39.00 | $0 | 100% | Dec 2023 |
|
FNY Investment Advisers | 1.00 | $0 | 100% | Dec 2023 |
|
Who sold out of Reviva Pharmaceutcls Hldgs I?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Rosalind Advisors | Dec 2023 | 196k | $1.0M |
J. Goldman & Co | Sep 2023 | 75k | $366k |
GSA Capital Partners | Sep 2023 | 70k | $342k |
Simplex Trading | Dec 2023 | 45k | $232k |
Gts Securities | Sep 2023 | 12k | $59k |
Ikarian Capital | Sep 2023 | 5.1k | $2.5M |